HDR Gateway logo
HDR Gateway logo

Bookmarks

The clinical and cost-effectiveness of testing for Group B Streptococcus: a cluster randomised trial with economic and acceptability evaluations (GBS3)

Safe People

Organisation name

University of Nottingham

Organisation sector

Academic Institute

Applicant name(s)

Jane Daniels

Funders/ Sponsors

NIHRHealth Technology Assessment (HTA)

Safe Projects

Project ID

nnrd13

Lay summary

Does routine testing of women for Group B Streptococcus (GBS) colonisation either in late pregnancy or during labour reduce the occurrence of early-onset neonatal sepsis, compared to the current risk factor based strategy?

Other approval committees

REC Reference: 19/EM/0253

Safe Setting

Access type

Release